Combination immunotherapy with anti-CD20 and anti-HLA-DR monoclonal antibodies induces synergistic anti-lymphoma effects in human lymphoma cell lines. [electronic resource]
Producer: 20071023Description: 944-56 p. digitalISSN:- 1042-8194
- Antibodies, Monoclonal -- chemistry
- Antibodies, Monoclonal, Murine-Derived
- Antigens, CD20 -- biosynthesis
- Antineoplastic Agents -- therapeutic use
- Caspase 3 -- metabolism
- Cell Line, Tumor
- Cell Survival
- Complement System Proteins
- Drug Screening Assays, Antitumor
- Enzyme Activation
- HLA-DR Antigens -- therapeutic use
- Humans
- Immunotherapy -- methods
- Lymphoma -- immunology
- Poly(ADP-ribose) Polymerases -- metabolism
- Rituximab
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.